These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8557252

  • 41. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T.
    Cancer Res; 1999 Dec 01; 59(23):5995-8. PubMed ID: 10606247
    [Abstract] [Full Text] [Related]

  • 42. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
    Kluwe L, Mautner VF.
    Hum Genet; 1996 Feb 01; 97(2):224-7. PubMed ID: 8566958
    [Abstract] [Full Text] [Related]

  • 43. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.
    Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, MacCollin M.
    Am J Hum Genet; 1997 Dec 01; 61(6):1293-302. PubMed ID: 9399891
    [Abstract] [Full Text] [Related]

  • 44. Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.
    Castellanos E, Plana A, Carrato C, Carrió M, Rosas I, Amilibia E, Roca-Ribas F, Hostalot C, Castillo A, Ros A, Quer A, Becerra JL, Salvador H, Lázaro C, Blanco I, Serra E, Bielsa I, for CSUR Phakomatoses Multidisciplinary Clinics HUGTiP-ICO-IGTP.
    JAMA Dermatol; 2018 Mar 01; 154(3):341-346. PubMed ID: 29322178
    [Abstract] [Full Text] [Related]

  • 45. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
    Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, Maher ER.
    J Neurosurg; 1996 May 01; 84(5):847-51. PubMed ID: 8622160
    [Abstract] [Full Text] [Related]

  • 46. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.
    Kehrer-Sawatzki H, Udart M, Krone W, Baden R, Fahsold R, Thomas G, Schmucker B, Assum G.
    Hum Genet; 1997 Jul 01; 100(1):67-74. PubMed ID: 9225971
    [Abstract] [Full Text] [Related]

  • 47. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
    Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L.
    Hum Mutat; 2008 Feb 01; 29(2):227-31. PubMed ID: 18072270
    [Abstract] [Full Text] [Related]

  • 48. Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients.
    Pećina-Slaus N, Zeljko M, Pećina HI, Nikuseva Martić T, Bacić N, Tomas D, Hrasćan R.
    Croat Med J; 2012 Aug 01; 53(4):321-7. PubMed ID: 22911524
    [Abstract] [Full Text] [Related]

  • 49. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
    Sanson M, Marineau C, Desmaze C, Lutchman M, Ruttledge M, Baron C, Narod S, Delattre O, Lenoir G, Thomas G.
    Hum Mol Genet; 1993 Aug 01; 2(8):1215-20. PubMed ID: 8401504
    [Abstract] [Full Text] [Related]

  • 50. [Analysis of NF2 gene mutations in intraspinal Schwannomas].
    Liu S, Chen S, Zhang K, Lin J, Yang Q, Zhang Y, Liu S, Liu S.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Oct 10; 34(5):637-641. PubMed ID: 28981922
    [Abstract] [Full Text] [Related]

  • 51. Genetic landscape of sporadic vestibular schwannoma.
    Håvik AL, Bruland O, Myrseth E, Miletic H, Aarhus M, Knappskog PM, Lund-Johansen M.
    J Neurosurg; 2018 Mar 10; 128(3):911-922. PubMed ID: 28409725
    [Abstract] [Full Text] [Related]

  • 52. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N, Whaley J, Seizinger BR.
    Glia; 1995 Nov 10; 15(3):297-307. PubMed ID: 8586465
    [Abstract] [Full Text] [Related]

  • 53. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK, Buckley PG, Benetkiewicz M, De Bustos C, Hirvelä C, Jarbo C, Bruder CE, Wensman H, Mathiesen T, Nyberg G, Papi L, Collins VP, Ichimura K, Evans G, Dumanski JP.
    Int J Oncol; 2003 Mar 10; 22(3):615-22. PubMed ID: 12579316
    [Abstract] [Full Text] [Related]

  • 54. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.
    Wallace AJ, Watson CJ, Oward E, Evans DG, Elles RG.
    Genet Test; 2004 Mar 10; 8(4):368-80. PubMed ID: 15684865
    [Abstract] [Full Text] [Related]

  • 55. The genomic landscape of schwannoma.
    Agnihotri S, Jalali S, Wilson MR, Danesh A, Li M, Klironomos G, Krieger JR, Mansouri A, Khan O, Mamatjan Y, Landon-Brace N, Tung T, Dowar M, Li T, Bruce JP, Burrell KE, Tonge PD, Alamsahebpour A, Krischek B, Agarwalla PK, Bi WL, Dunn IF, Beroukhim R, Fehlings MG, Bril V, Pagnotta SM, Iavarone A, Pugh TJ, Aldape KD, Zadeh G.
    Nat Genet; 2016 Nov 10; 48(11):1339-1348. PubMed ID: 27723760
    [Abstract] [Full Text] [Related]

  • 56. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
    Mohyuddin A, Neary WJ, Wallace A, Wu CL, Purcell S, Reid H, Ramsden RT, Read A, Black G, Evans DG.
    J Med Genet; 2002 May 10; 39(5):315-22. PubMed ID: 12011146
    [Abstract] [Full Text] [Related]

  • 57. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
    Diebold R, Bartelt-Kirbach B, Evans DG, Kaufmann D, Hanemann CO.
    J Mol Diagn; 2005 Feb 10; 7(1):97-104. PubMed ID: 15681480
    [Abstract] [Full Text] [Related]

  • 58. Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.
    Kino T, Takeshima H, Nakao M, Nishi T, Yamamoto K, Kimura T, Saito Y, Kochi M, Kuratsu J, Saya H, Ushio Y.
    Genes Cells; 2001 May 10; 6(5):441-54. PubMed ID: 11380622
    [Abstract] [Full Text] [Related]

  • 59. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
    Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN.
    J Neuropathol Exp Neurol; 1998 Dec 10; 57(12):1164-7. PubMed ID: 9862639
    [Abstract] [Full Text] [Related]

  • 60. Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene.
    Sestini R, Vivarelli R, Balestri P, Ammannati F, Montali E, Papi L.
    Hum Genet; 2000 Oct 10; 107(4):366-71. PubMed ID: 11129337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.